Penalty Amount
$29,600,000
Attorney General Phil Weiser joined a bipartisan coalition of 48 states and territories in announcing a $29.6 million settlement with Glenmark Pharmaceuticals. The settlement resolves allegations that Glenmark participated in a widespread conspiracy to inflate prices, reduce competition, and restrain trade for numerous generic prescription drugs. Glenmark also agreed to cooperate in ongoing multistate litigation and implement internal reforms.
Glenmark must pay $29.6 million, cooperate in ongoing multistate litigation against other defendants, and implement internal reforms to strengthen antitrust compliance and promote fair competition.
In-house legal teams should review vendor agreements with generic drug manufacturers for any clauses that could facilitate price-fixing or market allocation, such as information-sharing provisions, pricing coordination terms, or non-compete clauses. Customer contracts with pharmacies and distributors should be examined for any pricing mechanisms that might be influenced by collusion. Additionally, internal compliance programs and employee training materials should be updated to emphasize antitrust law requirements and the prohibition of communications with competitors regarding pricing or market division.
Entity
Glenmark Pharmaceuticals
Industry
Healthcare"Glenmark Pharmaceuticals"
"$29.6 million settlement"
"antitrust laws"
"conspiracy to inflate prices, reduce competition, and restrain trade"
"bipartisan coalition of 48 states and territories"
$29.6M
Minnesota Attorney General Keith Ellison joined a 48-state coalition in a $29.6 million settlement with generic-drug manufacturer Glenmark to resolve allegations of a widespread conspiracy to artificially inflate and manipulate prices, reduce competition, and restrain trade for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate lawsuits and implement internal reforms to ensure compliance with antitrust laws.
$29.6M
Oregon Attorney General Dan Rayfield and a bipartisan coalition of states reached a $29.6 million settlement with Glenmark, a generic drug manufacturer accused of conspiring with other pharmaceutical companies to inflate prices and limit competition for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate litigations and implement internal reforms to ensure fair competition and antitrust compliance.
Colorado joined a coalition of states and local governments in suing the National Highway Traffic Safety Administration over its rule weakening fuel economy standards for new passenger cars and light trucks. The coalition alleges the rule violates federal law; the press release does not report a penalty or a court ruling.
Colorado Attorney General Phil Weiser joined a multistate and local coalition challenging the EPA’s repeal of greenhouse gas limits for many coal- and gas-fired power plants. The coalition seeks to have the repeal struck down and the protections restored, and separately notified the EPA of its intent to sue over regulation of emissions from existing gas plants; no penalty or final court remedy is reported.
$469.0M
Colorado joined a 43-state-and-territory settlement resolving allegations that Sandoz and Fougera participated in a long-running conspiracy to inflate generic drug prices, reduce competition, and restrain trade. The companies agreed to pay approximately $469 million and implement reforms; the states are seeking court approval.
$35.0M
Colorado, the FTC, and a coalition of state attorneys general reached a settlement with Corteva over allegations that its post-patent loyalty program restricted distributors from selling competing generic pesticides. Corteva must end the challenged conduct and pay the states $35 million for fees and costs; the agreement is in effect for 10 years.